Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15356542 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
Condition: Chronic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Levocetirizine plus Hydroxyzine

Indicates status has not been verified in more than two years